Tag: COMPASS trial
Digging deep into DOACs for PAD post-revascularization in fight to stave...
This advertorial is sponsored by ACHL.
“It’s really sad—but it’s true: In the PAD space, we’re really behind. We’re behind in our understanding of the...
Combining aspirin with rivaroxaban reduces risk equally in presence or absence...
In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative degree of benefit on coronary, cerebrovascular and peripheral endpoints in patients...